Axe oncologie, Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada.
Centre de recherche sur le cancer de l'Université Laval, Québec, QC, Canada.
Front Immunol. 2024 Jun 3;15:1372837. doi: 10.3389/fimmu.2024.1372837. eCollection 2024.
The localization, density but mostly the phenotype of tumor infiltrating lymphocytes (TIL) provide important information on the initial interaction between the host immune system and the tumor. Our objective was to assess the prognostic significance of T (CD3), T regulatory (T) (FoxP3) and T memory (T) (CD45RO) infiltrating lymphocytes and of genes associated with TIL in prostate cancer (PCa).
Immunohistochemistry (IHC) was used to assess the infiltration of CD3, FoxP3 and CD45RO cells in the tumor area, tumor margin and adjacent normal-like epithelium of a series of 98 PCa samples with long clinical follow-up. Expression of a panel of 31 TIL-associated genes was analyzed by Taqman Low-Density Array (TLDA) technology in another series of 50 tumors with long clinical follow-up. Kaplan-Meier and Cox proportional hazards regression analyses were performed to determine association of these markers with biochemical recurrence (BCR), need for definitive androgen deprivation therapy (ADT) or lethal PCa.
TIL subtypes were present at different densities in the tumor, tumor margin and adjacent normal-like epithelium, but their density and phenotype in the tumor area were the most predictive of clinical outcomes. In multivariate analyses, a high density of T (high FoxP3/CD3 cell ratio) predicted a higher risk for need of definitive ADT (HR=7.69, p=0.001) and lethal PCa (HR=4.37, p=0.04). Conversely, a high density of T (high CD45RO/CD3 cell ratio) predicted a reduced risk of lethal PCa (HR=0.06, p=0.04). TLDA analyses showed that a high expression of FoxP3 was associated with a higher risk of lethal PCa (HR=5.26, p=0.02). Expression of CTLA-4, PD-1, TIM-3 and LAG-3 were correlated with that of FoxP3. Amongst these, only a high expression of TIM-3 was associated with a significant higher risk for definitive ADT in univariate Cox regression analysis (HR=3.11, p=0.01).
These results show that the proportion of T and T found within the tumor area is a strong and independent predictor of late systemic progression of PCa. Our results also suggest that inhibition of TIM-3 might be a potential approach to counter the immunosuppressive functions of T in order to improve the anti-tumor immune response against PCa.
肿瘤浸润淋巴细胞(TIL)的定位、密度,尤其是表型,提供了宿主免疫系统与肿瘤最初相互作用的重要信息。我们的目的是评估前列腺癌(PCa)中 T(CD3)、调节性 T(Treg)(FoxP3)和记忆性 T(Tmem)(CD45RO)浸润淋巴细胞以及与 TIL 相关的基因的预后意义。
使用免疫组织化学(IHC)评估了 98 例具有长期临床随访的 PCa 样本的肿瘤区域、肿瘤边缘和相邻正常样上皮中 CD3、FoxP3 和 CD45RO 细胞的浸润情况。使用 Taqman 低密度阵列(TLDA)技术分析了另一组 50 例具有长期临床随访的肿瘤中一组 31 个与 TIL 相关的基因的表达情况。采用 Kaplan-Meier 和 Cox 比例风险回归分析来确定这些标志物与生化复发(BCR)、是否需要确定性雄激素剥夺治疗(ADT)或致命性 PCa 的关系。
TIL 亚型在肿瘤、肿瘤边缘和相邻正常样上皮中的密度不同,但肿瘤区域中 TIL 的密度和表型是预测临床结局的最具预测性的因素。在多变量分析中,高 T 密度(高 FoxP3/CD3 细胞比)预示着需要确定性 ADT 的风险更高(HR=7.69,p=0.001)和致命性 PCa(HR=4.37,p=0.04)。相反,高 T 密度(高 CD45RO/CD3 细胞比)预示着致命性 PCa 的风险降低(HR=0.06,p=0.04)。TLDA 分析表明,FoxP3 高表达与致命性 PCa 的风险增加相关(HR=5.26,p=0.02)。CTLA-4、PD-1、TIM-3 和 LAG-3 的表达与 FoxP3 的表达相关。在这些基因中,只有 TIM-3 的高表达在单变量 Cox 回归分析中与确定性 ADT 的显著更高风险相关(HR=3.11,p=0.01)。
这些结果表明,肿瘤区域内 T 和 T 的比例是 PCa 晚期全身进展的强烈和独立的预测因子。我们的结果还表明,抑制 TIM-3 可能是一种潜在的方法,可以对抗 T 的免疫抑制功能,从而提高针对 PCa 的抗肿瘤免疫反应。